265 related articles for article (PubMed ID: 35740492)
1. Protein Farnesylation on Nasopharyngeal Carcinoma, Molecular Background and Its Potential as a Therapeutic Target.
Kobayashi E; Kondo S; Dochi H; Moriyama-Kita M; Hirai N; Komori T; Ueno T; Nakanishi Y; Hatano M; Endo K; Sugimoto H; Wakisaka N; Yoshizaki T
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740492
[TBL] [Abstract][Full Text] [Related]
2. C-Terminal Farnesylation of UCH-L1 Plays a Role in Transport of Epstein-Barr Virus Primary Oncoprotein LMP1 to Exosomes.
Kobayashi E; Aga M; Kondo S; Whitehurst C; Yoshizaki T; Pagano JS; Shackelford J
mSphere; 2018; 3(1):. PubMed ID: 29435490
[TBL] [Abstract][Full Text] [Related]
3. Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein-Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma.
Yao JJ; Zhou GQ; Wang YQ; Wang SY; Zhang WJ; Jin YN; Zhang F; Li L; Liu LZ; Cheng ZB; Ma J; Qi ZY; Sun Y
Chin J Cancer; 2017 Dec; 36(1):98. PubMed ID: 29284539
[TBL] [Abstract][Full Text] [Related]
4. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.
Lo AK; Lung RW; Dawson CW; Young LS; Ko CW; Yeung WW; Kang W; To KF; Lo KW
J Pathol; 2018 Oct; 246(2):180-190. PubMed ID: 29968360
[TBL] [Abstract][Full Text] [Related]
5. Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma.
Hau PM; Lung HL; Wu M; Tsang CM; Wong KL; Mak NK; Lo KW
Front Oncol; 2020; 10():600. PubMed ID: 32528868
[TBL] [Abstract][Full Text] [Related]
6. Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy.
Hu J; Li Y; Li H; Shi F; Xie L; Zhao L; Tang M; Luo X; Jia W; Fan J; Zhou J; Gao Q; Qiu S; Wu W; Zhang X; Liao W; Bode AM; Cao Y
Theranostics; 2020; 10(26):11921-11937. PubMed ID: 33204320
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr Virus Induces Lymphangiogenesis and Lympth Node Metastasis via Upregulation of VEGF-C in Nasopharyngeal Carcinoma.
Li DK; Chen XR; Wang LN; Wang JH; Wen YT; Zhou ZY; Li JK; Liu JX; Cai LB; Zhong SS; Lyu XM; Damola FO; Li MY; Zhang JJ; Zeng YM; Wang QL; Zhang QB; Lyu H; Fu XY; Wang W; Li X; Huang ZX; Yao KT
Mol Cancer Res; 2022 Jan; 20(1):161-175. PubMed ID: 34654722
[TBL] [Abstract][Full Text] [Related]
8. Molecular diagnosis of nasopharyngeal carcinoma using detection of Epstein-Barr virus latent membrane protein-1 gene in cervical metastatic lymph nodes.
Khademi B; Mahmoudi J; Monabati A; Maghsoudi B; Ashraf MJ; Mohammadianpanah M; Tabibi N; Valibeigi B; Abedi E
Am J Otolaryngol; 2009; 30(2):95-100. PubMed ID: 19239950
[TBL] [Abstract][Full Text] [Related]
9. The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma.
Tsang CM; Tsao SW
Virol Sin; 2015 Apr; 30(2):107-21. PubMed ID: 25910483
[TBL] [Abstract][Full Text] [Related]
10. FGF8b oncogene mediates proliferation and invasion of Epstein-Barr virus-associated nasopharyngeal carcinoma cells: implication for viral-mediated FGF8b upregulation.
Lui VW; Yau DM; Cheung CS; Wong SC; Chan AK; Zhou Q; Wong EY; Lau CP; Lam EK; Hui EP; Hong B; Hui CW; Chan AS; Ng PK; Ng YK; Lo KW; Tsang CM; Tsui SK; Tsao SW; Chan AT
Oncogene; 2011 Mar; 30(13):1518-30. PubMed ID: 21119603
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus infection and nasopharyngeal carcinoma.
Tsao SW; Tsang CM; Lo KW
Philos Trans R Soc Lond B Biol Sci; 2017 Oct; 372(1732):. PubMed ID: 28893937
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr Virus latent membrane protein 1 induces Snail and epithelial-mesenchymal transition in metastatic nasopharyngeal carcinoma.
Horikawa T; Yoshizaki T; Kondo S; Furukawa M; Kaizaki Y; Pagano JS
Br J Cancer; 2011 Mar; 104(7):1160-7. PubMed ID: 21386845
[TBL] [Abstract][Full Text] [Related]
13. Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma.
Chung GT; Lou WP; Chow C; To KF; Choy KW; Leung AW; Tong CY; Yuen JW; Ko CW; Yip TT; Busson P; Lo KW
J Pathol; 2013 Nov; 231(3):311-22. PubMed ID: 23868181
[TBL] [Abstract][Full Text] [Related]
14. K252a induces anoikis-sensitization with suppression of cellular migration in Epstein-Barr virus (EBV)--associated nasopharyngeal carcinoma cells.
Ng YK; Wong EY; Lau CP; Chan JP; Wong SC; Chan AS; Kwan MP; Tsao SW; Tsang CM; Lai PB; Chan AT; Lui VW
Invest New Drugs; 2012 Feb; 30(1):48-58. PubMed ID: 20694504
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus latent membrane protein 1 (LMP1) regulates the aldehyde dehydrogenase (ALDH) positive cell population in nasopharyngeal carcinoma cell lines.
Wu J; Su H; Li G; Huang Y
Acta Virol; 2019; 63(3):322-327. PubMed ID: 31507199
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs serving as potential biomarkers and therapeutic targets in nasopharyngeal carcinoma: A critical review.
Lee KT; Tan JK; Lam AK; Gan SY
Crit Rev Oncol Hematol; 2016 Jul; 103():1-9. PubMed ID: 27179594
[TBL] [Abstract][Full Text] [Related]
17. Genome-Wide Analysis of 18 Epstein-Barr Viruses Isolated from Primary Nasopharyngeal Carcinoma Biopsy Specimens.
Tu C; Zeng Z; Qi P; Li X; Yu Z; Guo C; Xiong F; Xiang B; Zhou M; Gong Z; Liao Q; Yu J; He Y; Zhang W; Li X; Li Y; Li G; Xiong W
J Virol; 2017 Sep; 91(17):. PubMed ID: 28637758
[TBL] [Abstract][Full Text] [Related]
18. Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type.
Leung SF; Chan AT; Zee B; Ma B; Chan LY; Johnson PJ; Lo YM
Cancer; 2003 Jul; 98(2):288-91. PubMed ID: 12872347
[TBL] [Abstract][Full Text] [Related]
19. Nasopharyngeal Carcinoma: The Role of the EGFR in Epstein-Barr Virus Infection.
Peng X; Zhou Y; Tao Y; Liu S
Pathogens; 2021 Aug; 10(9):. PubMed ID: 34578147
[TBL] [Abstract][Full Text] [Related]
20. Detection of methylation status of Epstein-Barr virus DNA C promoter in the diagnosis of nasopharyngeal carcinoma.
Zheng XH; Wang RZ; Li XZ; Zhou T; Zhang JB; Zhang PF; Lu LX; Jia WH
Cancer Sci; 2020 Feb; 111(2):592-600. PubMed ID: 31834989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
